Literature DB >> 30683186

Re: Bonini et al.: Phase 2 randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis (Ophthalmology. 2018;125:1332-1343).

Darren Shu Jeng Ting1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30683186     DOI： 10.1016/j.ophtha.2018.09.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  A corneal ring ulcer.

Authors:  Khaled Alhajraf; Shawn R Lin; Deborah S Jacobs
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-05

2.  Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy.

Authors:  Emilio Pedrotti; Erika Bonacci; Chiara Chierego; Alessandra De Gregorio; Tiziano Cozzini; Tommaso Brighenti; Grazia Caldarella; Giovanlorenzo Pastore; Adriano Fasolo; Giorgio Marchini
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.